Mean (SD)/n (%) | Median (IQR) | |
---|---|---|
Female gender | 217 (56.5) | |
Age (years) | 45.8 (14.7) | 44.8 (34.7-58.1) |
Arthritis duration (days) | 38.0 (30.0) | 31 (10-62) |
SJC (0-68) | 4.5 (6.7) | 2.0 (1-5) |
TJC (0-28) | 3.2 (5.0) | 1.0 (0-4) |
ESR (mm/h) | 31 (24) | 24 (12-48) |
ESR >20 mm/h | 214 (56.0) | |
CRP (mg/l) | 32 (47) | 15 (5-43) |
CRP >10 mg/l | 224 (58.3) | |
IgM RF positive | 38 (11.4) | |
ACPA positive | 49 (14.3) | |
Assessor's global VAS (mm) | 36 (21) | 32 (19-50) |
Patient's global VAS (mm) | 52 (25) | 53 (35-71) |
Joint pain VAS (mm) | 51 (26) | 52 (29-72) |
Fatigue VAS (mm) | 40 (29) | 40 (11-65) |
Morning stiffness >1 hour | 195 (50.8) | |
DAS28 | 4.01 (1.34) | 3.90 (3.06-4.82) |
HAQ (0-3) | 0.84 (0.67) | 0.75 (0.25-1.25) |
SF-36: | ||
PCS | 33.4 (10.8) | 32.8 (25.1-40.4) |
MCS | 48.6 (11.4) | 50.4 (40.1-57.4) |
Ever smoker | 236 (61.5) |